A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction in UTIs and improves QoL. Reducing hospital admissions (from 3 to 1 per patient, annually) would free \>100,000 bed-nights, allowing the elderly to regain independence. Our proposed research could have a significant impact towards fulfilling the 'healthy-ageing' Grand Challenge. Additionally, the novel stent reduces pr

Trial Details

NCT ID
NCT06815120
Phase
NA
Sponsor
University of Southampton
Status
RECRUITING
Cancer Type
Kidney Cancer
Interventions
  • Experimental ureteric stent with specially shaped side-holes that prevent stagnation points (i.e., areas of low flow that cause particles to settle and E&B)
  • Qualitative interview
Locations (sample)
  • Southampton, England, United Kingdom|50.90395,-1.40428
  • London, London, United Kingdom|51.50853,-0.12574

Key Eligibility Criteria

  • Aged 18 years or over
  • Ureteric stents clinically indicated either due to kidney stones or abdominal/pelvic cancers compressing ureters
  • Previous experience with ureteric stents
  • Awaiting insersion/replacement of stents

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Kidney Cancer Trials on Trialify →